James Mccloskey II in Hackensack, New Jersey

Home New Jersey Hackensack

James Mccloskey II has Hematology/oncology as his primary medical specialty. Their primary office is: 92 2nd St in Hackensack, New Jersey. There is an additional office location, for a total of two, for James Mccloskey II that can be viewed further down.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 201-996-5900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Georgetown University School Of Medicine and graduated in 2008 (around 16 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

James Kevin Mccloskey II Office Phone and Directions

James Mccloskey II
Regional Cancer Care Associates Llc
92 2nd St
Hackensack, New Jersey 07601
201-996-5900

Patient Ratings
Please rate your experience with James Mccloskey II below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 201-996-5900

Enter a starting address:

Healthcare Info for James Mccloskey II

Medical School: Georgetown University School Of Medicine
Graduation Year: 2008
The Primary Medical Specialty for James Mccloskey II is listed as: Hematology/oncology
Approximate Years of Experience: 16
PAC (PECOS ID)#: 8325265705
NPI #: 1992951149
NPI Created On: 08/07/2008
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207RH0000X
License Number:
25MA09444800
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Humana
Oscar Garden State Insurance Corporation
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Bone marrow biopsy and aspiration
Complete blood cell count (red cells, white blood cell, platelets), automated test
Bone marrow, smear interpretation
Routine electrocardiogram (ekg) with tracing using at least 12 leads
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, 30 minutes or less
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, epoetin alfa, (for non-esrd use), 1000 units

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,350

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 795578985

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $4,744

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731247

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731257

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731259

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731261

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731263

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731265

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731267

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731269

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01

Payments Total: $1,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731271

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01

Additional Office Locations

1. Regional Cancer Care Associates Llc
3800 Reservoir Rd Nw
Washington, DC 20007
Group Members: 111

Phone: 201-996-5900

Enter a starting address:

Hematology/oncology Professionals in Hackensack

1.
Mark Pascal

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

2.
Richard Scher DO

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

3.
Harry Harper

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

4.
Sukhdeep Kaur

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

5.
Robert Tassan MD

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

6.
Kelley Mowatt Pesce

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group